Center for Collaboration on Research Design & Analysis

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Rheumatoid Arthritis 74%
3. Veterans 41%
4. Proteomics 36%
5. Neoplasms 32%
6. Genes 30%
7. North American Indians 29%
8. Corpus Luteum 25%
9. HIV-1 25%
10. gemcitabine 24%
11. Periodontitis 24%
12. Metabolomics 23%
13. Porphyromonas gingivalis 22%
14. Growth 22%
15. African Americans 21%
16. Root Planing 20%
17. Health 20%
18. Gene Expression 19%
19. Alveolar Bone Loss 19%
20. Simian Immunodeficiency Virus 19%
21. Mucins 18%
22. Smoking 18%
23. mAb-AR20.5 18%
24. Dinoprost 18%
25. Minocycline 18%
26. Body Mass Index 18%
27. Autoantibodies 18%
28. UDP-GlcNAc GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase 18%
29. Phosphorylation 18%
30. Anti-Citrullinated Protein Antibodies 17%
31. Proteins 17%
32. Adenocarcinoma 17%
33. Toll-Like Receptor 4 17%
34. Hypoxia-Inducible Factor 1 16%
35. Proteome 16%
36. Pesticides 16%
37. Glucose 16%
38. Macaca mulatta 15%
39. Single Nucleotide Polymorphism 15%
40. Cigarette Smoking 15%
41. United States Department of Veterans Affairs 15%
42. Datasets 14%
43. Pancreatectomy 14%
44. Substance-Related Disorders 14%
45. Blood-Brain Barrier 14%
46. Herbicides 13%
47. Vitamin D 13%
48. Insulin Resistance 13%
49. Cell Movement 13%
50. Microspheres 13%
51. Antibodies 13%
52. Logistic Models 13%
53. Neoplasm Metastasis 13%
54. Confidence Intervals 13%
55. Hypothyroidism 12%
56. HIV 12%
57. Cattle 12%
58. tert-Butyl Alcohol 12%
59. Zyxin 12%
60. Macrophages 12%
61. HLA-DRB1 Chains 12%
62. Thyroid Diseases 12%
63. Glutamine 12%
64. Mortality 12%
65. Child 11%
66. Molecular Motor Proteins 11%
67. Carcinogenesis 11%
68. Polysaccharides 11%
69. Veterans Health 11%
70. Insecticides 11%
71. Lysophosphatidic Acid Receptors 11%
72. Silybin 10%
73. Pulvinar 10%
74. Acanthosis Nigricans 10%
75. tat Gene Products 10%
76. Public Health 10%
77. Medicare 10%
78. Reaction Time 10%
79. Tandem Mass Spectrometry 10%
80. Maintenance 10%
81. Conservation of Natural Resources 10%
82. Cross-Sectional Studies 10%
83. Public Health Practice 10%
84. Randomized Controlled Trials 9%
85. Chronic Periodontitis 9%
86. Transcriptome 9%
87. Bayes Theorem 9%
88. Epitopes 9%
89. Virus Diseases 9%
90. Therapeutics 9%
91. Gout 9%
92. Vascular Calcification 9%
93. Observational Studies 9%
94. Acetaldehyde 9%
95. Patient Acceptance of Health Care 9%
96. Absenteeism 9%
97. Rheumatic Fever 9%
98. Population Health 9%
99. Inflammation 9%